The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated, high throughput platform to receive FDA 510(k) clearance. […]
Early Warning System combines Spike protein structural modeling with artificial intelligence (AI) to detect and monitor high-risk SARS-CoV-2 variants, identifying >90% of WHO-designated variants on […]
…to enable rapid differentiation of viral respiratory infections The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with […]
The cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission Accurate detection and […]
It exceeds the sensitivity of other tests on the market. A super-sensitive test to detect coronavirus antibodies has been developed in Valencia The Technological Institute […]
• Elecsys® Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein • The spike protein is the target of many COVID-19 vaccines in […]
• Immunocompromised transplant patients are at risk of major complications when infected with BK virus • cobas BKV test addresses critical need for hospitals and […]
• First commercial test for fully automated high throughput systems to detect and differentiate SARS-CoV-2, influenza A virus and/or influenza B virus with a single […]
• Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions • Antigen test accurately […]
• Detects, confirms and differentiates HIV-1 and HIV-2 infections providing clinicians with critical diagnostic data for personalised management of patients with HIV – from appropriate […]
Letter to Clinical Laboratory Staff and Health Care Providers The U.S. Food and Drug Administration (FDA) recommends that clinical laboratories and health care providers stop […]
….to help in identifying patients at high risk of severe inflammatory response • FDA EUA1 now makes IL-6 testing accessible to patients in the United […]
The Nagel-Group is used to respond flexible to fluctuating demand in retail. The panic buying at the beginning of the COVID-19 pandemic nevertheless presented an […]
SEAT will carry out PCR tests on its 15,000 employees to ensure their health and safety and avoid COVID-19 infections. The carmaker has decided today […]
The U.S. Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19. Specifically, the FDA re-issued the emergency use […]
Copyright © 2023 | WordPress Theme by MH Themes
